Adenovirus-based gene therapy vectors now in use cannot be targeted to specific cell types in vivo and are immunogenic, properties which limit their clinical utility. Improved vectors lacking the genes for viral structural proteins may overcome these limitations. We have developed cell lines which stably express the adenovirus type 5 (Ad5) fibre protein in its native trimeric form. These cells can complement
Introduction
Adenovirus (Ad)-based vectors can efficiently transfer genes into many cell and tissue types (reviewed in Kozarsky & Wilson, 1993) , but they cannot yet be targeted to specific cell types and are frequently immunogenic in vivo. Ad vector replication, including expression of the late genes encoding viral structural proteins, is blocked by deletion of the essential E1a gene. Viral late gene expression has been detected following in vivo administration (Dai et al., 1997 ; Yang et al., 1994) , however, and a cytotoxic T lymphocyte (CTL) response against newly synthesized viral proteins can lead to inflammatory responses and to elimination of transduced cells (Dai et al., 1997 ; Yang et al., 1996) .
Vectors lacking additional viral genes are expected to be more replication-defective, and packaging cell lines for propagation of Ad which lack the genes encoding E1 and E4 products, the E2a DNA-binding protein, terminal protein and DNA polymerase (Amalfitano et al., 1996 ; Brough et al., 1996 ; Caravokyri & Leppard, 1995 ; Engelhardt et al., 1994 ; Gorziglia et al., 1996 ; Graham et al., 1977 ; Krougliak & Graham, 1995 ;  Author for correspondence : Glen R. Nemerow. an Ad5 mutant with a defect in the fibre gene, and are capable of incorporating the Ad5 fibre into particles of a different Ad serotype. As the fibre protein is responsible for the initial binding of virus to cells, packaging cell lines expressing different or modified fibre proteins will be useful in studying the mechanism by which adenovirus infects different cell types. Langer & Schaack, 1996 ; Schaack et al., 1995 ; Wang et al., 1995 ; Weinberg & Ketner, 1983 ; Yeh et al., 1996 ; Zhou et al., 1996) have been described. Most of these genes encode regulatory rather than structural proteins, and their deletion blocks late gene expression indirectly. Viral vectors produced by these systems also retain the broad cell tropism of wild-type Ad.
Alternatively, viral capsid proteins might be produced by the host cells and the corresponding genes removed from the vector chromosome. In addition to preventing expression of the deleted genes post-administration and thereby blocking the CTL response directed against their products, this strategy should allow retargeting of vectors via growth in cell lines producing modified structural proteins. The fibre protein is an attractive target for such manipulation because of its role in promoting virus attachment to cells (Bergelson et al., 1997 ; Philipson et al., 1968 ; Tomko et al., 1997) .
The homotrimeric fibre protein (composed of 62 kDa monomers in Ad5) forms the prominent spike at each vertex of the icosahedral viral particle. Initial attachment of virus to cells occurs via binding of the fibre to CAR, a 46 kDa cell surface protein with homology to the immunoglobulin superfamily (Bergelson et al., 1997 ; Tomko et al., 1997) . Ad internalization is subsequently mediated by interaction of the viral penton base protein with cellular α v integrins (Wickham et al., 1993) . As cell tropism is largely determined by the initial binding step, modification of the fibre protein to bind different receptors should alter the cell type(s) targeted by the vector (Gall et al., 1996 ; Stevenson et al., 1995) . This approach should be applicable to any cell type which expresses α v integrins to support virus internalization.
We have developed 293-based cell lines that stably express the Ad5 fibre protein in its native trimeric conformation, and which can complement both fibre mutant Ad and standard E1-deleted vectors. These packaging cells will facilitate the development of helper-independent Ad vectors lacking the fibre gene, and be useful in exploring the process of Ad infection.
Methods
Cell and viruses. Unless otherwise noted, cells were maintained in DMEM supplemented with 10 % foetal calf serum. 293 cells (Graham et al., 1977) and Ad serotypes 3 and 5 were purchased from the ATCC. Ad.RSVβgal (Stratford-Perricaudet et al., 1992) was the gift of Michel Perricaudet (Institut Gustave-Roussy). The H5ts142 fibre mutant (CheeSheung & Ginsberg, 1982) was kindly provided by Harold Ginsberg (Columbia University).
Cells were infected with Ad at the indicated p.f.u.\cell ratios and virus was harvested 2-3 days later. Virus was released from cells by four rapid freeze-thaw cycles and cellular debris was removed with a 10 min spin at 1500 g. The supernatant was titred without further purification in virus growth experiments. Titres were determined by fluorescent focus unit (FFU) assay using a polyclonal anti-penton base antibody (Wickham et al., 1993 ; Thiel & Smith, 1967) . Ad3 particles for use in immunoblotting experiments were further purified by two sequential centrifugations (3 h at 111 000 g) on preformed 15-40 % CsCl gradients to remove soluble cellular proteins and then dialysed extensively against 10 mM Tris-HCl, pH 8n1, 150 mM NaCl, 10 % glycerol.
Plasmid constructs. To create pcDNA3\Fibre, the fibre open reading frame (ORF) was amplified from Ad5 genomic DNA using the oligonucleotides 5h ATG GGA TCC AAG ATG AAG CGC GCA AGA CCG 3h and 5h CAT AAC GCG GCC GCT TCT TTA TTC TTG GGC 3h, and inserted into the BamHI and NotI sites of pcDNA3 (Invitrogen) via novel restriction sites (bold type) designed into the primers. The 5h oligonucleotide also contains a G to A change three nucleotides 5h of the ATG codon (underlined) designed to improve the consensus for translation initiation (Kozak, 1986) . To create pCLF, a BglII fragment containing the tripartite leader of Ad5 was excised from pRD112a (Sheay et al., 1993) and inserted into the unique BamHI site just upstream of the fibre ATG in pcDNA3\Fibre.
For pE4\Hygro, DNA corresponding to nucleotides 32667-35780 of Ad5 (Chroboczek et al., 1992) was amplified using primers E4L (5h CGG TAC ACA GAA TTC AGG AGA CAC AAC TCC 3h) and E4R (5h GCC TGG ATC CGG GAA GTT ACG TAA CGT GGG AAA AC 3h). This fragment was cloned into the EcoRI and BamHI sites of pBluescript SK via novel restriction sites in the primers (bold type), along with a hygromycin resistance cassette excised from pMEP4 (Invitrogen) by digestion with FspI, addition of BamHI linkers (5h CGCGGATCCGCG 3h), and BamHI digestion. DNA sequence confirmation was performed by the Protein and Nucleic Acid Core Facility of the Scripps Research Institute using an ABI\Perkin Elmer 373 automated fluorescent sequencer with FS dye terminator chemistry.
Production and characterization of stable cell lines. DNA for electroporation was prepared using the Qiagen system according to the manufacturer's instructions. 293 cells were grown in RPMI mediumj10 % foetal calf serum, and 4i10' cells were electroporated with 20 µg of DNA using a Bio-Rad GenePulser at settings of 300 V and 25 µF. Following electroporation, colonies were selected using either 200 µg\ml hygromycin B (Sigma) or 800 µg\ml neomycin (Gibco). Lines transfected with pCLF were screened for fibre protein expression by indirect immunofluorescence. The presence of integrated E4 DNA was assessed by PCR using primers E4R and E4L (see above) from genomic DNA (microTurbogen, Invitrogen), and by Southern blotting as described (Sambrook et al., 1989) using the Genius nonradioactive detection kit (Boehringer Mannheim) according to the manufacturer's instructions.
Immunoprecipitation assay. Cells (approximately 10( per sample) were labelled with 50 µCi\ml $&S-Translabel (ICN) for 2 h at 37 mC, lysed in RIPA buffer, and fibre protein immunoprecipitated as described (Harlow & Lane, 1988 ) using a rabbit polyclonal antibody. Immune complexes were collected on Protein A-Sepharose beads (Pierce), extensively washed with RIPA buffer, and incubated at room temperature in 30 µl 0n1 M triethylamine, pH 11n5, to release bound fibre protein. Samples were then electrophoresed on a 8 % SDS-PAGE gel under denaturing (1 % SDS in loading buffer, samples boiled for 5 min) or semi-native (0n1 % SDS in loading buffer, samples not heated) conditions. Gels were fixed, treated with Amplify fluorography reagent (Amersham), dried and exposed to film.
Immunofluorescent staining. Cells were grown overnight on polylysine-coated eight-well chamber slides and fixed with 3 % paraformaldehyde in PBS for 20 min at room temperature. After washing with PBS, the cells were permeabilized by room temperature incubation in PBS containing 0n2 % Triton X-100 for 3 min. Gelatin (0n2 %) was included in all post-Triton incubations and washes. Cells were incubated with a rabbit anti-fibre polyclonal antibody (Wickham et al., 1993) diluted 1 : 500 for 60 min at 37 mC, washed, and incubated with an FITCconjugated secondary antibody (Kirkegaard and Perry Laboratories) for 60 min at 37 mC. Cells were then washed in PBS-gelatin followed by PBS, and mounted.
Immunoblotting. Samples were electrophoresed on 8-16 % precast SDS-PAGE gels (Novex) and transferred to Immobilon P membrane (Millipore). After blocking overnight in 10 % nonfat dry milk-PBS at 4 mC, the blot was incubated at 37 mC with a polyclonal rabbit anti-fibre serum. After washing, the signal was detected with a horseradish peroxidase-conjugated goat anti-rabbit antibody (Kirkegaard and Perry Laboratories) and the ECL chemiluminescence substrate (Amersham).
Recombinant Ad2 fibre protein. Recombinant Ad2 fibre protein was expressed in baculovirus-infected insect cells and purified by anionexchange chromatography as previously described (Wickham et al., 1993) .
Results

Generation of cells constitutively expressing fibre protein
The Ad5 fibre gene was placed under the control of the CMV promoter (Fig. 1 ) in order to provide strong constitutive transcription. It is important to ensure that fibre production will continue during vector packaging, which is equivalent to the late phase of a productive viral infection. At this time, Ad shuts off host cell protein synthesis by inactivating a host cell translation initiation factor (Zhang et al., 1994) . Efficient translation of late viral messages is maintained by inclusion of the tripartite leader (TPL), composed of three exons totalling about 200 nt which are spliced onto the 5h end of late viral mRNAs (Chow et al., 1997 ; Akusja$ rvi & Pettersson, 1979) . This sequence is thought to function by providing a less ordered structure at the 5h end of the mRNA, conferring independence from the host cell initiation complex (Dolph et al., 1988) . To ensure continued translation of the recombinant fibre message, a fragment containing the Ad5 TPL was inserted at the 5h end of the fibre gene in pcDNA3\fibre to create pCLF (Fig. 1 B) . Addition of this sequence has been previously reported to increase levels of protein expression even in uninfected cells (Sheay et al., 1993) .
Expression of fibre protein from pCLF and pcDNA3\fibre was initially evaluated by transient assay in 293 cells. When cells were electroporated with pcDNA3\fibre (lacking the TPL), fibre expression 48 h later was barely visible by indirect immunofluorescence staining. In contrast, cells electroporated with pCLF produced fibre at high levels, as seen by very bright nuclear staining in many cells (data not shown). Based on this result, pCLF was chosen for production of stable cell lines. pE4\Hygro ( Fig. 1 C) was designed to provide complementation of E4-deleted viral vectors without the need for induction of E4 expression, and therefore includes the entire E4 transcriptional unit including its native promoter and terminator and all E4 ORFs.
293 cells were cotransfected with pCLF and pE4\Hygro, followed by selection with hygromycin to establish clones containing integrated DNA. Of a total of 63 lines evaluated by PCR analysis, only one (designated 211) carried a complete E4 insert. Presence of the intact E4 fragment was confirmed by Southern blotting (data not shown). The cells also displayed somewhat different growth properties than the parental 293 line, growing more slowly and forming a more even monolayer in plaque assays.
Line 211 did not express the fibre protein as detected by immunofluorescence staining. As we wished to generate lines which both contained the E4 insert and expressed fibre, these cells were retransfected with pCLF. Several of the sublines proved to accumulate fibre protein in the cell nuclei, the site of Ad assembly (Fig. 2 A, B, C) . As a positive control, 293 cells were infected with the first-generation vector Ad.RSVβgal (Stratford-Perricaudet et al., 1992) , which carries its own fibre gene, and stained in parallel (Fig. 2 E) . The three lines shown here (211A, 211B and 211R) were selected for further characterization. Each of these lines expressed fibre at similar levels, which were somewhat below that seen in a normal Ad infection (Fig. 2) . From data like that shown in Fig. 2 , as well as Western blot experiments (not shown), we estimate that the cell lines express fibre at approximately 25 % of the level seen in Ad-infected cells. This level of fibre expression was maintained through at least 10 serial passages as well as freezing, liquid nitrogen storage and recovery of cells. Unfortunately, we found that line 211 and its fibre-expressing subclones did not reproducibly support the growth of E4 mutant Ad (data not shown). Further studies of E4 complementation by these cells were therefore not undertaken.
Trimeric structure of the recombinant fibre
As noted above, the native fibre protein is a homotrimer (Henry et al., 1994) , and trimerization is essential for assembly of the penton-fibre complex (Novelli & Boulanger, 1991) . To assess the multimeric structure of the recombinant fibre protein produced by the cell lines, cells were metabolically labelled with [$&S]methionine and fibre protein was immunoprecipitated BEGD under non-denaturing conditions from soluble cell extracts. As seen in Fig. 3 , the packaging cell lines 211A, 211B and 211R, but not the control 293 cells, expressed an immunologically reactive protein which migrated at the predicted molecular mass for trimer (186 kDa) under semi-native conditions and for monomer (62 kDa) under denaturing conditions. The behaviour of the expressed fibre was identical to that of baculovirus-produced recombinant Ad2 fibre (the Ad2 and Ad5 fibres behave identically in this gel system).
The recombinant fibre is functional
To determine whether the fibre-producing cell lines could support the growth of a fibre-defective Ad, we used the temperature-sensitive Ad fibre mutant H5ts142. At the restrictive temperature (39n5 mC), this mutant produces an underglycoslyated fibre protein which is not incorporated into mature viral particles (Chee-Sheung & Ginsberg, 1982) . This results in the accumulation of non-infectious viral particles. Growth of the mutant virus can be rescued at the restrictive temperature by coinfection with a wild-type helper virus, indicating that the defective mutant fibre does not have a large dominant negative effect on virus growth. We therefore asked whether the fibre protein expressed in our cell lines could complement the H5ts142 defect and rescue virus growth.
As shown in Fig. 4 , the fibre mutant virus replicated to high titres in 293 cells at 32n5 mC (the permissive temperature), but to a much lower extent at the restrictive temperature of 39n5 mC. The fibre-producing packaging lines 211A, 211B and 211R supported virus production at 39n5 mC to levels within 2-or 3-fold of those seen at the permissive temperature in 293 cells, indicating that these cells complemented the fibre defect.
Titres from the fibre-producing cell lines were also somewhat higher than those from 293 cells at 32n5 mC. This suggests that fibre produced by the ts142 virus may be partially defective even at the ' permissive ' temperature. Alternatively, our packaging cells might simply produce higher Ad yields, by a mechanism not involving fibre complementation. However, we have found that viruses with wildtype fibre genes (such as Ad.RSVβgal or wild-type Ad5) replicate to identical levels either in our packaging lines or in 293 cells (data not shown). Taken together, these results demonstrate that the increase in H5ts142 growth which we observed was due to specific complementation of the fibre mutation. 
Incorporation of Ad5 fibre into Ad3 particles
Although the fibre proteins of different Ad serotypes differ in the length of their shaft domains and in the receptor-binding knob domains, the N-terminal regions responsible for interaction with the viral penton base are highly conserved (Arnberg et al., 1997 ; Chroboczek et al., 1995) (Fig. 5 A) . This suggests that viral vectors equipped with different fibre proteins might be produced simply by growth in cells expressing fibres of different serotypes. To explore this possibility, Ad3 was grown in cells expressing the Ad5 fibre, to determine whether the recombinant Ad5 fibre protein produced by the cells might be incorporated into the Ad3 particles along with the native type 3 protein.
Ad3 was grown in the fibre-producing cells or in 293 cells, and virus was purified by two sequential CsCl gradient centrifugations. As demonstrated by immunoblotting (Fig.  5 B) , the purified virus contained Ad5 fibre protein after a single passage through a fibre-expressing cell line but not after passage through the parental 293 cells. This result demonstrates that the type 5 fibre protein is capable of stably interacting with the type 3 penton base, and that a viral vector of one serotype can be equipped with a different fibre simply by growth in a cell line that expresses the fibre protein of interest.
Discussion
Packaging cell lines complementing adenoviral vectors with deletions in a number of genes, most of which are regulatory rather than structural in nature, have been reported. We are interested in extending such technology to the major structural proteins of the virus. This strategy should be useful in developing targeted gene therapy vectors as well as in reducing vector immunogenicity. We initially chose to develop systems for expression of fibre because of its role in targeting viral infection to specific cell types.
The cell lines described here produce a functional Ad5 fibre protein, as shown by their ability to support growth of the H5ts142 mutant and to incorporate the recombinant fibre into Ad3 particles. Despite a previous report that fibre was toxic to cells (Levine & Ginsberg, 1967) , we found no evidence of toxicity due to constitutive expression, and expression of fibre could be maintained over many cell generations. The TPL cassette increased fibre protein expression even in the absence of viral infection, as previously reported (Sheay et al., 1993) .
The incomplete complementation of the ts142 defect by our cell lines may be due to their expression of fibre at a level somewhat below that seen in a wild-type infection. A recent study reported an E4-deleted vector which coincidentally reduced fibre protein expression, resulting in a large reduction in the titre of virus produced (Brough et al., 1996) . Development of inducible systems for fibre production is now in progress, in order to evaluate the effects of higher-level expression in packaging lines.
Expression of different or modified fibre proteins in packaging lines should allow the production of versatile, targeted gene therapy vectors. The conservation seen in the Nterminal penton-binding domain of fibre suggests that the fibre proteins from many virus serotypes, with their different cellbinding specificities, will be useful. A vector based on Ad5 but containing the gene for the Ad7 fibre protein has been described (Gall et al., 1996) , as well as Ad containing chimeric fibre genes (Krasnykh et al., 1996 ; Stevenson et al., 1997) . Addition of a short peptide linker to the fibre in order to confer binding to a different cellular protein has also been reported (Michael et al., 1995) . Previous work has demonstrated that the fibre protein from Ad2 is capable of interacting with the penton base protein from Ad3 (Fender et al., 1997) , and our result incorporating the type 5 fibre into type 3 particles extends these findings.
Replacing or modifying the fibre gene in the vector backbone requires that the new fibre protein bind a receptor on the surface of the cells in which it is grown. Packaging cell systems such as those described here will allow the generation of viruses containing a fibre which can no longer bind to its host cells, by a single round of growth in cells expressing the desired fibre gene. This will greatly expand the repertoire of fibre proteins which can be incorporated into particles. A vector which lacks the fibre gene could be retargeted by growth in cells producing a different fibre, without the timeconsuming step of generating a new viral chromosome for each application. We are now in the process of constructing such a fibreless vector. Viral particles lacking fibre may also be of interest. A novel fibre-independent pathway of infection has recently been described in haematopoietic cells, in which penton base provides the initial virus-cell interaction by binding to integrin α m β # (Huang et al., 1996) . This suggests that Ad lacking fibre protein may be useful in targeting gene delivery to specific cell types via this pathway.
Vectors lacking the fibre gene will also have a larger capacity for DNA insertion and be less likely to generate replication-competent virus via recombination than current E1-deleted vectors, and may be less immunogenic in vivo. While the fibre protein is not a major target of the antibody response which limits repeated vector administration (Gall et al., 1996) , its role in generating the CTL response responsible for eliminating infected cells remains to be determined. In vivo evaluation of vectors lacking the fibre gene will allow determination of the precise contribution of the fibre protein to the CTL response.
Adenoviral vectors deleted for all viral genes (' gutless ' vectors), with very high capacities for insertion of foreign DNA, have recently been reported (Kumar-Singh & Chamberlain, 1997 ; Haecker et al., 1996 ; Kochanek et al., 1997 ; Fisher et al., 1996 ; Mitani et al., 1995) . However, these must be grown in the presence of a helper virus which provides the necessary adenoviral gene products in trans-, and it has been difficult or impossible to isolate completely helper-free stocks of such viruses. By developing cell lines which complement multiple structural proteins, it may be feasible to produce helper-independent vectors with many of the advantages of the gutless vectors.
